- DCGEN
- DCGEN
- About DCGEN
patients, and their family with
Genomic analysis
Since the Human Genome Project, research on human genome information such as Precision Medicine, Big Data,
and Artificial Intelligence (AI) has continued to evolve. However, the fast-paced scientific achievement is not directly
connected to the patient's diagnosis and treatment.
So DCGEN wants to be a leader in the platform of genomic analysis.
-
Vision Making decisions for doctors,
patients, and their families based on
genomic analysis technology -
Mission Our in-depth genomic research and
abundant clinical experience help
reduce the gap between state-of-the-art
technology and patient care
DCGEN’s corporate identity is a visualization of the corporate value pursued by DCGEN. By visualizing the
double helix structure of the DNA in the corporate identity, we expressed the company's value to contribute
to the patient's treatment based on genetic analysis and expressed the trust between the customer and
DCGEN using blue color.
In each brand identity, a circle-shaped symbol using DNA double helix structure is inserted to form the perfect
trust between the customer and DCGEN. The logo of OncoFREE®, an in-vitro diagnostic for the prediction of
breast cancer prognosis, designed using the pink color that symbolizes breast cancer patients.
In each brand identity, a circle-shaped symbol using DNA double helix structure is inserted to form the perfect
trust between the customer and DCGEN. HOPE®, a hereditary cancer gene panel, has embodied high trust
by designing a logo using blue color.
